Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 53 min ago
Peer-reviewedLicence not statedTherapies

Isotonitazene, a synthetic opioid from an emerging family: The nitazenes

Related

  1. The gasdermin family in depression-associated neuroinflammation: established evidence, emerging mechanisms, and therapeutic perspectives
    Yang Luo, Ziming Liu, Huiqin Li +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  2. Opioid addiction vs. sugar addiction: Mesocorticolimbic stimulation controls motivation for remifentanil or alternative reward
    I. Morales, K. C. Berridge, D. Nguyen
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  3. Suzetrigine-evoked analgesia is potentiated by Nav1.7 null-related opioid mechanisms.
    E. V. Riquelme, O. Didenko, S. Gossage +3
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  4. Differential Time-Course Decreases in Nonselective, μ-, δ-, and κ-Opioid Receptors After Focal Cerebral Ischemia in Mice
    Hervé Boutin, François Dauphin, Eric Mackenzie +1
    StrokePeer-reviewedLicence not stated55 citedNeuroscienceHAL
  5. Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced μ-Opioid Receptor Regulation
    Géraldine Poisnel, Martine Dhilly, Reynald Le Boisselier +2
    Journal of Pharmacological SciencesPeer-reviewedLicence not statedFull text29 citedNeuroscienceHAL
BibTeX
@article{eiden2026isotonitazene,
  title = {{Isotonitazene, a synthetic opioid from an emerging family: The nitazenes}},
  author = {Céline Eiden and Margot Lestienne and Sabrina Cherki and David Gautre and Thomas van den Broek and Olivier Mathieu and Hélène Peyrière},
  journal = {Therapies},
  year = {2026},
  month = oct,
  doi = {10.1016/j.therap.2024.05.004},
  url = {https://hal.science/hal-05784852v1},
}
RIS
TY  - JOUR
TI  - Isotonitazene, a synthetic opioid from an emerging family: The nitazenes
AU  - Céline Eiden
AU  - Margot Lestienne
AU  - Sabrina Cherki
AU  - David Gautre
AU  - Thomas van den Broek
AU  - Olivier Mathieu
AU  - Hélène Peyrière
PY  - 2026
DA  - 2026/10/07
JO  - Therapies
DO  - 10.1016/j.therap.2024.05.004
UR  - https://hal.science/hal-05784852v1
SN  - 0040-5957
SN  - 1958-5578
ER  -